European Medicines Agency Warns of Actos Risks
The European Medicines Agency (EMA), the European Union agency responsible for evaluating medicinal products, recently advised that the maker of Actos, an important and popular diabetes medication, should clarify on-the-box warnings about the risks of Actos.
The EMA isn’t the only governmental agency concerned about the effects of Actos. The Food & Drug Administration (FDA) has also advised American patients and health care professionals as to the potentially hazardous effects of this drug. In particular, the FDA has warned that pioglitazone, an active ingredient in Actos, is linked to bladder cancer.
Have you taken Actos? You should be aware of the potential health – and legal – results of your Actos prescription. To find out what you should know, talk to the professionals and attorneys at the firm of Fears Nachawati. We may be able to help you. For a free consultation, call us at 1.866.545.8364 or email email@example.com.